The VLDLR entry receptor is required for the pathogenesis of multiple encephalitic alphaviruses

The very-low-density lipoprotein receptor (VLDLR) has been reported as an entry receptor for Semliki Forest (SFV) and Eastern equine encephalitis (EEEV) alphaviruses in cell cultures. However, the role of VLDLR in alphavirus pathogenesis and the extent to which other alphaviruses can engage VLDLR re...

Full description

Saved in:
Bibliographic Details
Published inCell reports (Cambridge) Vol. 43; no. 10; p. 114809
Main Authors Palakurty, Sathvik, Raju, Saravanan, Sariol, Alan, Chong, Zhenlu, Wagoner, Ngan, Ma, Hongming, Zimmerman, Ofer, Adams, Lucas J., Carmona, Camille, Liu, Zhuoming, Fremont, Daved H., Whelan, Sean P.J., Klimstra, William B., Diamond, Michael S.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 22.10.2024
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The very-low-density lipoprotein receptor (VLDLR) has been reported as an entry receptor for Semliki Forest (SFV) and Eastern equine encephalitis (EEEV) alphaviruses in cell cultures. However, the role of VLDLR in alphavirus pathogenesis and the extent to which other alphaviruses can engage VLDLR remains unclear. Here, using a surface protein-targeted CRISPR-Cas9 screen, we identify VLDLR as a receptor for Western equine encephalitis virus (WEEV) and demonstrate that it promotes the infection of multiple viruses in the WEE antigenic complex. In vivo studies show that the pathogenicity of WEEV, EEEV, and SFV, but not the distantly related Venezuelan equine encephalitis virus, is markedly diminished in VLDLR-deficient mice and that mice treated with a soluble VLDLR-Fc decoy molecule are protected against disease. Overall, these results expand our understanding of the role of VLDLR in alphavirus pathogenesis and provide a potential path for developing countermeasures against alphaviruses from different antigenic complexes. [Display omitted] •VLDLR is a receptor for several WEEV strains•Soluble VLDLR decoy neutralizes WEEV infection in vitro and in vivo•VLDLR KO mice survive lethal challenge by WEEV, SFV, and EEEV-MADV but not VEEV•VLDLR KO mice have decreased virus in the brain after intracranial WEEV infection Using a targeted CRISPR-Cas9 survival screen, Palakurty et al. identify the very-low-density lipoprotein receptor (VLDLR) as a receptor for Western equine encephalitis virus (WEEV) and other related viruses in its antigenic complex. Their experiments also demonstrate that the pathogenesis of multiple encephalitic alphaviruses is substantially reduced in VLDLR-deficient mice.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
AUTHOR CONTRIBUTIONS
S.P., S.R., and M.S.D. designed the study. S.P., S.R., O.Z., and Z.C. performed the screening, gene validation, and cell culture studies. C.C. generated key reagents used for some assays. S.R. and S.P. generated recombinant proteins and performed binding studies. A.S. and N.W. performed the infections in mice and virologic analysis. H.M., Z.L., and S.P.J.W. contributed to development of the CRISPR library in Hap1 cells. L.J.A. and D.H.F. supervised the protein binding studies. W.B.K. and M.S.D. secured funding and resources for the studies. S.P., S.R., and M.S.D. wrote the initial draft, with all other authors providing comments.
ISSN:2211-1247
2211-1247
DOI:10.1016/j.celrep.2024.114809